INS and Hyperglycemia: In a previous study, MSCs or their EVs, when administered to diabetic mice, significantly improve hyperglycemia [18–21], reduce glycosylated hemoglobin levels [21, 22], increase insulin secretion [18, 19], and improve hepatic glucose and lipid metabolism [23].